Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA clears Quidel's Strep A test:

This article was originally published in Clinica

Executive Summary

Quidel (US) has gained US FDA clearance for its rapid point- of-care Strep A test. The test will be marketed under two brand names - Card QS and Concise Performance Plus. "The launch of these products completes the integration of our acquisition of Pacific Biotech from Eli Lilly," said Steven Frankel, Quidel's president and CEO. Over 20 million Strep tests are performed annually in the US, generating a market of $50-60 million.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087928

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel